Cancer cells found in HNC, colorectal carcinoma, and non-small cell lung carcinoma (NSCLC) often acquire genetic amplification of EGFR, and EGFR-containing EVs are released from these cancer cells. Here, EGFR is linked to non-small cell lung carcinoma.